New Risk • Jun 26
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩153.7b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Minor Risk Market cap is less than US$100m (₩153.7b market cap, or US$99.9m). Announcement • Mar 13
DNF Co.,Ltd., Annual General Meeting, Mar 26, 2026 DNF Co.,Ltd., Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: dream hall, 190, daejeon-ro 1331beon-gil, daedeok-gu, daejeon South Korea Announcement • Feb 06
DNF Co.,Ltd. announces Annual dividend DNF Co.,Ltd. announced Annual dividend of KRW 100.0000 per share, ex-date on March 30, 2026 and record date on March 31, 2026. New Risk • Dec 16
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩144.6b (US$98.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Minor Risk Market cap is less than US$100m (₩144.6b market cap, or US$98.0m). New Risk • Aug 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change). Announcement • May 21
DNF Co.,Ltd. (KOSDAQ:A092070) announces an Equity Buyback for KRW 2,000 million worth of its shares. DNF Co.,Ltd. (KOSDAQ:A092070) announces a share repurchase program. Under the program, the company will repurchase KRW 2,000 million worth of its shares pursuant to a contract with KB Securities co., Ltd. The purpose of the program is to enhance shareholder value and to stabilize stock price. The program will be valid until November 19, 2025. As of May 19, 2025, the company had 187,780 shares in treasury under the dividend capacity and no shares in treasury under other capacities. New Risk • Mar 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Revenue has declined by 25% over the past year. Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (₩111.4b market cap, or US$76.9m). Announcement • Mar 12
DNF Co.,Ltd., Annual General Meeting, Mar 26, 2025 DNF Co.,Ltd., Annual General Meeting, Mar 26, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 190, daejeon-ro 1331beon-gil, daedeok-gu, daejeon South Korea Announcement • Dec 20
DNF Co.,Ltd. (KOSDAQ:A092070) announces an Equity Buyback for KRW 2,000 million worth of its shares. DNF Co.,Ltd. (KOSDAQ:A092070) announces a share repurchase program. Under the program, the company will repurchase KRW 2,000 million worth of its shares pursuant to a contract with KB Securities co.Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will be valid until June 19, 2025. As of December 19, 2024, the company had 0 shares in treasury under the dividend capacity and no shares in treasury under other capacities. Upcoming Dividend • Dec 20
Upcoming dividend of ₩200 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 15 April 2025. Trailing yield: 2.3%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (0.8%). New Risk • Nov 14
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Revenue has declined by 25% over the past year. Minor Risk Market cap is less than US$100m (₩111.4b market cap, or US$79.3m). New Risk • Sep 10
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩132.6b (US$98.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩132.6b market cap, or US$98.9m). New Risk • Jun 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Upcoming Dividend • Dec 20
Upcoming dividend of ₩200 per share at 0.9% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 12 April 2024. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.9%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%). New Risk • Aug 26
New major risk - Revenue and earnings growth Earnings have declined by 5.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 5.3% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.2% net profit margin). Valuation Update With 7 Day Price Move • Aug 14
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to ₩20,850, the stock trades at a trailing P/E ratio of 35.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years. Valuation Update With 7 Day Price Move • Jul 24
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩24,300, the stock trades at a trailing P/E ratio of 41.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 58% over the past three years. Valuation Update With 7 Day Price Move • Jul 04
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩20,200, the stock trades at a trailing P/E ratio of 34.7x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 45% over the past three years. Valuation Update With 7 Day Price Move • Mar 29
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₩17,750, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 127% over the past three years. Reported Earnings • Mar 26
Full year 2022 earnings released: EPS: ₩499 (vs ₩1,083 in FY 2021) Full year 2022 results: EPS: ₩499 (down from ₩1,083 in FY 2021). Revenue: ₩135.2b (up 6.4% from FY 2021). Net income: ₩5.77b (down 52% from FY 2021). Profit margin: 4.3% (down from 9.4% in FY 2021). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • Dec 21
Upcoming dividend of ₩200 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 30 April 2023. Payout ratio is a comfortable 14% but the company is not cash flow positive. Trailing yield: 1.5%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%). Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Jun 15
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₩16,800, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 144% over the past three years. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Upcoming Dividend • Dec 22
Upcoming dividend of ₩200 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 30 April 2022. Payout ratio is a comfortable 23% but the company is paying out more than the cash it is generating. Trailing yield: 1.0%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.5%). Valuation Update With 7 Day Price Move • Nov 30
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₩18,150, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 127% over the past three years. Announcement • Aug 12
DNF Co.,Ltd. announced that it has received KRW 20.9635764 billion in funding from Samsung Electronics Co., Ltd. On August 11, 2021, DNF Co.,Ltd. closed the transaction. Valuation Update With 7 Day Price Move • Jul 14
Investor sentiment improved over the past week After last week's 16% share price gain to ₩28,250, the stock trades at a trailing P/E ratio of 18.3x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 151% over the past three years. Valuation Update With 7 Day Price Move • Apr 24
Investor sentiment improved over the past week After last week's 19% share price gain to ₩26,000, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 123% over the past three years. Is New 90 Day High Low • Feb 09
New 90-day high: ₩27,150 The company is up 96% from its price of ₩13,850 on 11 November 2020. The South Korean market is up 24% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 30% over the same period. Is New 90 Day High Low • Jan 13
New 90-day high: ₩23,250 The company is up 69% from its price of ₩13,750 on 15 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 34% over the same period. Valuation Update With 7 Day Price Move • Dec 29
Investor sentiment improved over the past week After last week's 18% share price gain to ₩21,150, the stock is trading at a trailing P/E ratio of 26.3x, up from the previous P/E ratio of 22.3x. This compares to an average P/E of 15x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 54%. Is New 90 Day High Low • Dec 17
New 90-day high: ₩17,150 The company is up 20% from its price of ₩14,250 on 18 September 2020. The South Korean market is up 14% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 20% over the same period. Is New 90 Day High Low • Dec 02
New 90-day high: ₩16,550 The company is up 18% from its price of ₩14,050 on 03 September 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. Valuation Update With 7 Day Price Move • Nov 16
Market bids up stock over the past week After last week's 16% share price gain to ₩15,200, the stock is trading at a trailing P/E ratio of 18.9x, up from the previous P/E ratio of 16.3x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total return to shareholders over the past three years is a loss of 4.0%. Is New 90 Day High Low • Oct 26
New 90-day low: ₩12,100 The company is down 24% from its price of ₩15,850 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. Announcement • Jun 19
DNF Co.,Ltd. (KOSDAQ:A092070) entered into an agreement to acquire additional 35.723% stake in ChemOptics Inc. for KRW 7.9 billion. DNF Co.,Ltd. (KOSDAQ:A092070) entered into an agreement to acquire additional 35.723% stake in ChemOptics Inc. for KRW 7.9 billion on June 15, 2020. Under the terms, 0.8 million shares will be acquired at a ratio of 0.730025 as a part of the acquisition. Post the completion of the transaction DNF will hold 50.19% stake in ChemOptics and will operate as a subsidiary of DNF. ChemOptics reported total assets of KRW 22.7 billion, sales of KRW 22.4 billion and net loss of KRW 1.3 billion. The transaction is expected to close on July 1, 2020. 
